Advances in Chronic Kidney Disease
Volume 11, Issue 3 , Pages 328-333 , July 2004

Cardiovascular diseases in kidney transplant recipients: the role of anemia

  • Pradeep V Kadambi

      Affiliations

    • Section of Nephrology, Department of Medicine, University of Chicago, Pritzker School of Medicine, Chicago, IL, USA
    • ,
  • Basit Javaid

      Affiliations

    • Section of Nephrology, Department of Medicine, University of Chicago, Pritzker School of Medicine, Chicago, IL, USA
    • Corresponding Author InformationAddress correspondence to Basit Javaid, MD, Section of Nephrology, Department of Medicine, University of Chicago, Pritzker School of Medicine, 5841 South Maryland Avenue, Suite S-508, MC 5100, Chicago, IL 60637 USA

References 

  1. U.S. Renal Data System, USRDS 2003 Annual Data Report. Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD 2003;
  2. Ojo AO, Hanson JA, Wolfe RA, et al.  Long-term survival in renal transplant recipients with graft function. Kidney Int. 2000;57:307–313
  3. Hariharan S, Johnson CP, Bresnahan BA, et al.  Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med. 2000;342:605–612
  4. Sarnak MJ, Tighiouart H, Manjunath G, et al.  Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study. J Am Coll Cardiol. 2002;40:27–33
  5. Al-Ahmad A, Rand WM, Manjunath G, et al.  Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol. 2001;38:955–962
  6. Sarnak MJ, Levey AS, Schoolwerth AC, et al.  Kidney disease as a risk factor for development of cardiovascular disease (A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention). Circulation. 2003;108:2154–2269
  7. Gill JS, Pereira BJ. Chronic kidney disease and the transplant recipient. Blood Purif. 2003;21:137–142
  8. Rigatto C, Parfrey P, Foley R, et al.  Congestive heart failure in renal transplant recipients (Risk factors, outcomes, and relationship with ischemic heart disease). J Am Soc Nephrol. 2002;13(4):1084–1090
  9. Rigatto C, Foley R, Jeffery J, et al.  Electrocardiographic left ventricular hypertrophy in renal transplant recipients (Prognostic value and impact of blood pressure and anemia). J Am Soc Nephrol. 2003;14: 462–48
  10. Djamali A, Becker YT, Simmons WD, et al.  Increasing hematocrit reduces early posttransplant cardiovascular risk in diabetic transplant recipients. Transplantation. 2003;76:816–820
  11. Abbott KC, Hypolite IO, Hshieh P, et al.  Hospitalized congestive heart failure after renal transplantation in the United States. Ann Epidemiol. 2002;12:115–122
  12. Abbott KC, Bucci JR, Cruess D, et al.  Graft loss and acute coronary syndromes after renal transplantation in the United States. J Am Soc Nephrol. 2002;13:2560–2569
  13. Mix TC, Kazmi W, Khan S, et al.  Anemia (A continuing problem following kidney transplantation). Am J Transplant. 2003;3:1426–1433
  14. Yorgin PD, Scandling JD, Belson A, et al.  Late post-transplant anemia in adult renal transplant recipients. An under-recognized problem?. Am J Transplant. 2002;2:429–435
  15. Kim HC, Park SB, Han SY, et al.  Anemia following renal transplantation. Transplant Proc. 2003;35:302–303
  16. Karthikeyan V, Karpinski J, Nair RC, et al.  The burden of chronic kidney disease in renal transplant recipients. Am J Transplant. 2004;4:262–269
  17. Vanrenterghem Y, Ponticelli C, Morales JM, et al.  Prevalence and management of anemia in renal transplant recipients (A European survey). Am J Transplant. 2003;3:835–845
  18. Ponticelli C, Villa M. Role of anaemia in cardiovascular mortality and morbidity in transplant patients. Nephrol Dial Transplant. 2002;17(suppl 1):41–46
  19. Kiberd B, Keough-Ryan T, Panek R. Cardiovascular disease reduction in the outpatient kidney transplant clinic. Am J Transplant. 2003;3:1393–1399
  20. Silverberg DS, Wexler D, Iaina A. The importance of anemia and its correction in the management of severe congestive heart failure. Eur J Heart Fail. 2002;4(6):681–686
  21. Metivier F, Marchais SJ, Guerin AP, et al.  Pathophysiology of anaemia (Focus on the heart and blood vessels). Nephrol Dial Transplant. 2000;15(suppl 3):14–18
  22. Besarab A, Bolton WK, Browne JK, et al.  The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med. 1998;339:584–590
  23. Collins AJ. Anaemia management prior to dialysis (Cardiovascular and cost-benefit observations). Nephrol Dial Transplant. 2003;18(suppl 2):2–6
  24. Macdougall IC  Steering Committee of the CREATE trial, CREATE Study Group . CREATE (new strategies for early anemia management in renal insufficiency). Nephrol Dial Transplant. 2003;18(suppl 2):13–16
  25. Roger SD, McMahon LP, Clarkson A, et al.  Effects of early and late intervention with epoetin alpha on left ventricular mass among patients with chronic kidney disease (stage 3 or 4) (Results of a randomized clinical trial). J Am Soc Nephrol. 2004;15:148–156

PII: S1548-5595(04)00072-2

doi: 10.1053/j.arrt.2004.04.003

Advances in Chronic Kidney Disease
Volume 11, Issue 3 , Pages 328-333 , July 2004

Article Tools

* Image Usage & Resolution